Systemic fungal infection · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs not absorbed from GI tract showed no clear difference in systemic fungal infection compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Toxicity (adverse events probably due to drug) · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole,… showed no clear difference in toxicity (adverse events probably due to drug) compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Oral candidiasis (present) · Patients with cancer receiving chemotherapy and/or radiotherapy
Antifungal drugs absorbed from GI tract (fluconazole, ketoconazole,… led to lower oral candidiasis (present) compared with placebo or no treatment; GRADE not reported.
1 finding from 1 review
Tongue scraping (mechanical tongue cleaning) vs Placebo or no intervention (nothing)
Outcome not reported · Adults (over 18 years) with a clinical or self-assessed diagnosis of halitosis
The review found no eligible studies for this question.
1 finding from 1 review
Caries increment on permanent tooth surfaces (D(M)FS), prevented fraction · Children and adolescents aged 16 years or younger (permanent dentition)
7 findings from 1 review
Show 4 more findings
PF 0.28 [0.19, 0.37]
22 studies
GRADE not reported
PF 0.40 [0.31, 0.49]
17 studies
GRADE not reported
PF 0.24 [0.21, 0.28]
70 studies
GRADE not reported
PF 0.46 [0.30, 0.63]
7 studies
GRADE not reported
Psychosocial outcomes · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
The review found no eligible studies for this question.
1 finding from 1 review
Caries increment on primary (deciduous) tooth surfaces (d(e/m)fs), prevented fraction · Children with primary (deciduous) teeth (younger children)
5 findings from 1 review
PF 0.26 [-0.11, 0.63]
2 studies
GRADE not reported
PF 0.41 [0.26, 0.55]
2 studies
GRADE not reported
PF 0.27 [0.08, 0.48]
3 studies
GRADE not reported
Show 2 more findings
PF 0.33 [0.22, 0.44]
5 studies
GRADE not reported
PF 0.33 [0.19, 0.48]
3 studies
GRADE not reported
Caries increment on permanent whole teeth (D(M)FT), prevented fraction · Children and adolescents aged 16 years or younger (permanent dentition)
7 findings from 1 review
PF 0.26 [0.21, 0.30]
79 studies
GRADE not reported
PF 0.53 [0.23, 0.82]
3 studies
GRADE not reported
PF 0.32 [0.19, 0.46]
10 studies
GRADE not reported
Show 4 more findings
PF 0.45 [0.32, 0.58]
7 studies
GRADE not reported
PF 0.24 [0.18, 0.30]
13 studies
GRADE not reported
PF 0.24 [0.20, 0.28]
72 studies
GRADE not reported
PF 0.23 [0.19, 0.28]
53 studies
GRADE not reported
Headache (severity) · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment (OA) showed no clear difference in headache (severity) compared with placebo; GRADE not reported.
1 finding from 1 review
Pain (severity) · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment (OA) showed no clear difference in pain (severity) compared with placebo; GRADE not reported.
1 finding from 1 review
Adverse effects: dental fluorosis · Children and adolescents aged 16 years or less
The review found no eligible studies for this question.
1 finding from 1 review
Caries increment on permanent tooth surfaces (D(M)FS), prevented fraction · Children and adolescents aged 16 years or less
1 finding from 1 review
Proportion developing new caries · Children and adolescents aged 16 years or less
Fluoride toothpaste showed no clear difference in proportion of children developing one or more new caries compared with placebo (non-fluoride) toothpaste; GRADE not reported.
1 finding from 1 review
Quality of life · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects (tooth staining/discoloration, oral soft-tissue signs, adverse symptoms such as nausea/vomiting, enamel etching) · Children and adolescents aged 16 years or less
1 finding from 1 review
Data on adverse effects (stain score, proportion of children with tooth staining, signs of sensitivity in oral soft tissue, adverse symptoms such as nausea/vomiting, etching of enamel) were reported in only a few…
Studies not reported
GRADE not reported
Relief of globus · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment (OA) showed no clear difference in relief of globus compared with placebo; GRADE not reported.
1 finding from 1 review
Acquiring extrinsic tooth staining (adverse effect; stannous fluoride toothpaste) · Children and adolescents aged 16 years or less
Fluoride toothpaste led to higher acquiring extrinsic tooth staining (adverse effect; stannous… compared with placebo (non-fluoride) toothpaste; GRADE not reported.
1 finding from 1 review
Caries increment in deciduous teeth: df-rate, new decayed or filled teeth per 100 primary teeth (prevented fraction) · Children and adolescents aged 16 years or less
1 finding from 1 review
Headache (frequency) · Adults (aged 18 years or older) with clinically diagnosed temporomandibular disorders (TMD)
Occlusal adjustment (OA) showed no clear difference in headache (frequency) compared with placebo; GRADE not reported.
1 finding from 1 review
Adverse effects: dental fluorosis · Children and adolescents aged 16 years or less
The review found no eligible studies for this question.
1 finding from 1 review